News

FDA approves ketamine product for surgical pain management

The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.

FDA’s new expert panels are rife with financial conflicts and fringe views

A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...
Medscape14h

FDA Approves First-in-Class Drug for Fibromyalgia

Sublingual cyclobenzaprine (Tonmya), a nonopioid treatment for adults with fibromyalgia, targets nonrestorative sleep, a root ...

Novo Nordisk's Wegovy receives FDA approval to treat serious liver disease

CNBC's Angelica Peebles joins 'Squawk on the Street' to discuss the latest news on Novo Nordisk, what new FDA approval on its ...

Novo Nordisk Shares Rise After FDA Approves Wegovy for Liver Disease

Novo Nordisk shares climbed after the U.S. Food and Drug Administration approved a new indication for the Danish drugmaker’s ...

Drug Approvals Hit an FDA Wall

Therapies for rare and deadly disease are dying in Marty Makary’s shop.

Time is running out for kids with a rare disease, parents say, unless the FDA acts

After a more than decadelong process to bring the experimental drug elamipretide to market, the treatment’s approval has ...
BioPharma Dive16h

Stealth resubmits rare disease drug to FDA

The biotech, which cut jobs following the rejection in May of its Barth syndrome therapy, claimed it has addressed the agency ...
Healio16h

FDA warns whipped, mousse sunscreen formulations may be ineffective

The FDA’s recent issue of five warning letters to brands illegally marketing whipped, mousse and foam sunscreen products ...

Novo Nordisk's Wegovy Snags Conditional FDA Nod For Fatty Liver Disease

On Saturday, the U.S. Food and Drug Administration (FDA) approved an additional indication for Novo Nordisk A/S’ (NYSE:NVO) ...
STAT16h

Conflicts among CDC and FDA vaccine panel members are not as numerous as you think, study finds

Robert F. Kennedy Jr. has said the CDC's vaccine advisory board was rife with conflicts of interest. A new analysis shows ...
Fierce Biotech17h

Neurizon becomes second biotech hit with FDA delay for ALS candidate

Yet another biotech is facing a delay from the Food and Drug Administration as the agency reels from intense staffing cuts. | ...